1 |
曹会玲, 吴尚为. 肠道微生态研究技术在代谢综合征中的应用[J]. 中华临床实验室管理电子杂志, 2018, 6(1):10-14.
|
2 |
Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016, 64(1):73-84.
|
3 |
Karthikeyan G, Teo KK, Islam S, et al. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study[J]. J Am Coll Cardiol, 2009, 53(3):244-53.
|
4 |
Okamura T, Hashimoto Y, Hamaguchi M, et al. Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study[J]. Int J Obes, 2019, 43(1):139-148.
|
5 |
许海燕, 顼志敏, 陆宗良. 中国成人血脂异常防治指南(2007)概要与解读[J]. 中华老年心脑血管病杂志, 2008, 10(3):238-240.
|
6 |
Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation[J]. Am J Gastroenterol, 2007, 102(12):2708-2715.
|
7 |
中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊断标准[J]. 中华肝脏病杂志, 2003(2):8.
|
8 |
林林, 陈常中, 余晓丹. 应用Empower Stats软件分析阈值效应[J]. 中华流行病学杂志, 2013, 34(11):1139-1141.
|
9 |
Borrelli A, Bonelli P, Tuccillo FM, et al. Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches[J]. Redox Biol, 2018, 15:467-479.
|
10 |
Chen SH, He F, Zhou HL, et al. Relationship between nonalcoholic fatty liver disease and metabolic syndrome[J]. J Dig Dis, 2011, 12(2):125-130.
|
11 |
骆善彩, 陈晓敏, 过晓阳, 等. 代谢综合征各组分与非酒精性脂肪肝发生的回顾性巢式病例对照研究[J]. 现代预防医学, 2016, 43(16):2921-2925.
|
12 |
Alkassabany YM, Farghaly AG, El-Ghitany EM. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt[J]. Arab J Gastroenterol, 2014, 15(2):76-81.
|
13 |
DeFilippis AP, Blaha MJ, Martin SS, et al. Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis[J]. Atherosclerosis, 2013, 227(2):429-36.
|
14 |
Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults[J]. Aliment Pharmacol Ther, 2011, 34(3):274-85.
|
15 |
颜应琳, 于凯, 王拥军, 等. 河北省任丘老年居民甘油三酯和高密度脂蛋白胆固醇比值与胰岛素抵抗的关系[J]. 中国慢性病预防与控制, 2016, 24(5):328-331.
|
16 |
Can AS, Uysal C, Palaoğlu KE. Short term effects of a low-carbohydrate diet in overweight and obese subjects with low HDL-C levels[J]. BMC Endocr Disord, 2010, 10:18.
|
17 |
Dowla S, Aslibekyan S, Goss A, et al. Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease[J]. J Clin Lipidol, 2018, 12(4):981-987.
|
18 |
黄佳斯, 李晶, 陈若虹, 等. 湖南地区7671名成人血脂水平分析[J]. 中华临床实验室管理电子杂志, 2014, 2(4):246-251.
|
19 |
Guo-Chao Zhong, Su-Qun Huang, Yang Peng, et al. HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies[J]. Eur J Prev Cardiol, 2020, 27(11):1187-1203.
|
20 |
Rader DJ, Tall AR. The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis?[J]. Nat Med, 2012, 18(9):1344-1346.
|
21 |
Feng M, Darabi M, Tubeuf E, et al. Free cholesterol transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis underlies the U-shape relationship between HDL-cholesterol and cardiovascular disease[J]. Eur J Prev Cardiol, 2020, 27(15):1606-1616.
|